This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07612/identifier/pubchem-substance/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07612/identifier/drugbank/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07612/identifier/chemspider/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/ontology/drugbank/
n5http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/drugbank/drug/DB07612/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07612/identifier/pubchem-compound/

Statements

Subject Item
n2:DB07612
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n10:DB07612 n14:DB07612
dcterms:title
6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE
adms:identifier
n7:DB07612 n8:D23 n11:4450261 n12:5288016 n13:99444083
n4:IUPAC-Name
n5:271B5543-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B5549-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B5548-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B5545-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B5546-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B5547-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B5541-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B5542-363D-11E5-9242-09173F13E4C5 n5:271B553F-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B5540-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B554F-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B5550-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B554A-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B554B-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B554D-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B554C-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B554E-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B5555-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B5557-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B5558-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B5554-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B5553-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B5556-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B5544-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B5551-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B5552-363D-11E5-9242-09173F13E4C5